VASCULAR INJURY CORRECTION IN ARTERIAL HYPERTENSION: FOCUS ON PERINDOPRIL

Por Yu. N. Belenkov, E. V. Privalova, Yu. A. Danilogorskaya, E. A. Zheleznykh, A. A. Shchendrygina
Publicado em 2012-06-01

INFLUENCE OF THE COMBINATION DRUG PRESTANS (PERINDOPRIL A, AMLODIPINE) ON MORPHO-FUNCTIONAL PARAMETERS OF ARTERIAL BED IN ESSENTIAL HYPERTENSION

Por Yu. A. Danilogorskaya, E. A. Zheleznykh, E. V. Privalova, A. A. Shchendrygina, Yu. N. Belenkov, I. S. Ilgisonis, M. I. Tishman
Publicado em 2017-12-01

Changes in Post-COVID Syndrome Manifestations and Bulbar Conjunctival Angioscopy Results in a Patient Undergoing Treatment after Mild COVID-19

Por V. V. Arkhipov, T. S. Kheilo, E. G. Gladysheva, Yu. A. Danilogorskaya, M. R. Dzhavatkhanova, S. V. Snytko, I. V. Samorukova, M. V. Zhuravleva
Publicado em 2022-04-01

EFFECTS OF PERINDOPRIL, TELMISARTAN, AND THEIR COMBINATIONS ON CLINICAL, FUNCTIONAL, AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELL...

Por Yu. N. Belenkov, E. V. Privalova, E. A. Zheleznykh, Yu. A. Danilogorskaya, I. S. Chekneva, O. A. Azizova, A. V. Aseychev, A. G. Shvachko
Publicado em 2010-04-01

Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus

Por Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis
Publicado em 2019-07-01

Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches

Por A. A. Shchendrygina, K. A. Zhbanov, E. V. Privalova, A. O. Yusupova, Yu. A. Danilogorskaya, E. Yu. Salakheeva, I. Ya. Sokolova, S. A. Tsatsurova, A. A. Ageeva, Yu. N. Belenkov
Publicado em 2021-07-01